Memantine Augmentation in Obsessive-Compulsive Disorder
Trial ID or NCT#
NCT00264238
Status
NOT RECRUITING
Purpose
The purpose of this study is to determine whether memantine is safe and effective when used as an augmentation to standard treatment for Obsessive-Compulsive Disorder (OCD).
Official Title
An Open-Label Trial of Memantine to Augment Response in the Treatment of Obsessive-Compulsive Disorder
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - at least 18 years of age - suffering from OCD - Y-BOCS score of 18 or greater - taking a therapeutic dose of an anti-OCD medication specified in the protocol
Exclusion Criteria:
- - diagnosed with a mental disorder other than OCD - taking tiagabine or pregabalin - having had a previous trial of memantine - receiving therapy for OCD - substance abuse in the last 6 months - personality disorders sufficiently severe to interfere with study participation
Investigator(s)
John Barry, MD
Psychiatrist
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult) and, by courtesy, of Neurology
Contact us to find out if this trial is right for you.
Contact
Nona Gamel
6507238601
View on ClinicalTrials.gov
